Business
NeuroOne Medical Technologies Corporation Announces Reverse Stock Split as Part of Uplisting Strategy to Major Exchange
EDEN PRAIRIE, Minn., March 31 , 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne or the Company), a medical technology
About this update from Neuroone Medical Technologies Corporation
[{"type":"text","content":"EDEN PRAIRIE, Minn., March 31 , 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-3, effective at 4:01 pm Eastern time today. Beginning tomorrow, April 1, 2021, NeuroOne's common stock will trade on a split-adjusted basis.\n\n \n \n \n \n \n \n\n \nDave Rosa, CEO of NeuroOne Medical Technologies Corporation says, \"As part of our corporate strategy to uplist to a major exchange, we are excited to take the next step in this process. In addition to our existing shareholder base, we are grateful to our new institutional investors that have provided important growth capital to launch new products and uplist the company. We look forward to updating the market on our future progress as we move forward with a major national exchange.\"\nUpon effectiveness, the reverse split will cause every 3 shares of NeuroOne's issued and outstanding common stock to be automatically combined and converted into 1 issued and outstanding share of common stock, par value $0.001 per share. The reverse stock split will reduce the number of shares of common stock issuable upon the exercise or vesting of its outstanding stock options, restricted stock units and warrants in proportion to the ratio of the reverse stock split and causes a proportionate increase in the exercise prices of such stock options and warrants.\nNeuroOne's common stock will continue to trade on the OTCQB under the symbol \"NMTC.\" The new CUSIP number for the common stock following the reverse split is 64130M 209.\nAbout NeuroOneNeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. For more information, visit https://www.n1mtc.com.\nOn February 23, 2021, the Company announced it had successfully met the first performance m...